Please choose your application, enter the information requested below. * Marked fields are mandatory.
Product Description
GNE-6776 is a selective USP7 inhibitor.
IC50 & Target: USP7[1]
In Vitro: GNE-6776 non-covalently targets USP7 12 Å distant from the catalytic cysteine. GNE-6776 attenuates ubiquitin binding and thus inhibits USP7 deubiquitinase activity. GNE-6776 interacts with acidic residues that mediate hydrogen-bond interactions with the ubiquitin Lys48 side chain. GNE-6776 targets cellular USP7, MDM2, and p53 signalling pathways.GNE-6776 selectively inhibits recombinant USP7 relative to 36 other deubiquitinases. GNE-6776 remains selective even at 100 μM, a more than sixfold higher concentration than used in cellular assays. GNE-6776 significantly inhibits USP7 while remaining selective against 44-47 other detected deubiquitinases[1].
In Vivo: Although efficacious exposure is only transiently achieved, GNE-6776 causes modest, although significant, EOL-1 xenograft growth delay[1].
Information
CAS No2009273-71-4
FormulaC20H20N4O2
Clinical Informationclinicalinformation
PathwayCell Cycle/DNA Damage
TargetDeubiquitinase
Specifications
Purity / Grade>98%
SolubilityDMSO : ≥ 310 mg/mL (889.78 mM)
Smilessmiles
Misc Information
Observed Molecular Weight348.4
related data
Get valuable resources and offers directly to your email.